Skip to main content
AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.260
+0.007 (2.73%)
Oct 31, 2024, 4:00 PM EDT - Market closed

AIM ImmunoTech Revenue

AIM ImmunoTech had revenue of $50.00K in the quarter ending June 30, 2024, with 19.05% growth. This brings the company's revenue in the last twelve months to $201.00K, up 19.64% year-over-year. In the year 2023, AIM ImmunoTech had annual revenue of $202.00K with 43.26% growth.

Revenue (ttm)
$201.00K
Revenue Growth
+19.64%
P/S Ratio
62.90
Revenue / Employee
$7,179
Employees
28
Market Cap
16.46M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023202.00K61.00K43.26%
Dec 31, 2022141.00K6.00K4.44%
Dec 31, 2021135.00K-28.00K-17.18%
Dec 31, 2020163.00K23.00K16.43%
Dec 31, 2019140.00K-227.00K-61.85%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cumberland Pharmaceuticals 37.79M
ImmunoPrecise Antibodies 17.44M
Sol-Gel Technologies 6.56M
HCW Biologics 3.92M
Synlogic 3.17M
QT Imaging Holdings 3.11M
Talphera 398.00K
GeoVax Labs 300.68K
Revenue Rankings

AIM News

More News